Alprazolam in treating secondary depression
Thweatt, R.W.
Journal of Clinical Psychiatry 48(12): 497
1987
ISSN/ISBN: 0160-6689 PMID: 3693338 Document Number: 303722
Document emailed within 1 workday
Related Documents
Kravitz, H.M.; Fawcett, J.; Newman, A.J. 1993: Alprazolam and depression: a review of risks and benefits Journal of Clinical Psychiatry 54(Suppl): 78-84Moulin, C.H.; Rolachon, A.; Cohard, M.; Girard, M.; Bichard, P.; Pasquier, D.; Mallaret, M.; Zarski, J.P. 1994: Fulminant hepatitis secondary to alprazolam Therapie 49(4): 362-363
Fabre, L.F. 1976: Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression Current Therapeutic Research 19(6): 661-668
Srisurapanont, M.; Boonyanaruthee, V. 1997: Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect Journal of the Medical Association of Thailand 80(3): 183-188
Levy, A.B.; Davis, J.; Bidder, T.G. 1984: Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report Journal of Clinical Psychiatry 45(11): 480-481
Sheehan, D.V.; Sheehan, K.H.; Raj, B.A. 2007: The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder Psychopharmacology Bulletin 40(2): 63-81
Worrall, G.; Angel, J. 2000: Diagnosing and treating depression. Educating family physicians to recognise depression Bmj 320(7249): 1602; Author Reply 1603-4
Singh, R.; Mazi-Kotwal, N.; Thalitaya, M.D. 2015: Recognising and Treating Depression in the Elderly Psychiatria Danubina 27(Suppl 1): S231-S234
Schatzberg, A.F. 2003: Introduction: treating depression and anxiety to remission Journal of Clinical Psychiatry 64 Suppl. 15: 3-4
2014: Magnetic brain stimulation. Role in treating depression Mayo Clinic Health Letter 32(7): 7
Moran, M. 2004: Treating Depression as Chronic Brings Positive Results Psychiatric News 39(24): 2-33
Frances, A.J.; Kahn, D.A.; Carpenter, D.; Docherty, J.P.; Donovan, S.L. 1998: The Expert Consensus Guidelines for treating depression in bipolar disorder Journal of Clinical Psychiatry 59 Suppl. 4: 73-79
Zorumski, C.F.; Rutherford, J.L.; Burke, W.J.; Reich, T. 1986: ECT in primary and secondary depression Journal of Clinical Psychiatry 47(6): 298-300
McCluskey, P.J.; Hall, A.J.; Lightman, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease Medical Journal of Australia 164(8): 484-486
Duflou, J.; Marriott, D. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.20 HIV and autopsies Medical Journal of Australia 164(10): 616-617
Frankum, B.S.; Savdie, E. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.10 HIV and renal disease Medical Journal of Australia 164(8): 483
Wong, D.; Shumack, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease Medical Journal of Australia 164(6): 352-356
Araya, R.; Rojas, G.; Fritsch, R.; Gaete, J.; Rojas, M.; Simon, G.; Peters, T.J. 2003: Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial Lancet 361(9362): 995-1000
Sievert, W.; Shaw, D.R.; Edwards, P. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.3 HIV, gastrointestinal and hepatobiliary disease Medical Journal of Australia 164(6): 360-365
Hoy, J.F.; Marriott, D.; Gottlieb, T. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection Medical Journal of Australia 164(9): 543-545